Background: Impaired artery elasticity has been found in various pathological conditions related to endothelial dysfunction. Recently, CD31ϩ/CD42Ϫ microparticles (MPs) emerged as a marker of endothelial injury. Whether CD31ϩ/CD42Ϫ MPs, generated under physiological conditions, are correlated with artery properties has not been reported.
A rtery elasticity has proved to be a sensitive parameter for evaluating artery function 1 and a potent predictor of future cardiovascular events in a number of settings. 2 Although age, blood-pressure levels, and genetic deposition were shown to be involved in alterations of artery elasticity, 3 other factors that affect artery elasticity should still be investigated to understand better the influence of potential novel mechanisms in artery elasticity. It is well accepted that the mechanical properties of arteries may be largely regulated both by structural changes of the vascular wall and by alterations in the local concentrations of vasoactive substances mainly released by endothelial cells. 4 Recently, the essential role of vascular endothelium in the regulation of artery elasticity has drawn much attention, because endothelial dysfunction was found in different conditions with profoundly impaired artery elasticity. [5] [6] [7] It was shown that vascular endothelium may switch to procoagulant, proinflammatory, and vasoconstrictive properties in response to various cardiovascular risk factors. 8 The loss of functional and structural integrity in vascular endothelium eliminates its capability to regulate homeostasis of the artery, encourages cellular infiltration into the artery wall, and prompts smooth muscle cell proliferation and new collagen crosslinking, which may partly explain the progression of arteriosclerosis. 9 However, because of the influence of coexisting risk factors to both the endothelium and vascular elasticity on the whole, as well as the lack of suitable measurements of instant endothelial phenotypic changes, the molecular mechanisms underlying the detrimental effects of impaired endothelial cells per se on vascular elasticity need further investigation.
Endothelial microparticles (EMPs) emerged recently as a marker of endothelial injury. 10 Changes in membrane phospholipids and proteins that EMPs carry from their parent cells were believed to reflect endothelial perturbation. Elevations of EMPs, mostly defined as CD31ϩ/ CD42Ϫ microparticles (MPs), in the circulation, as well as alterations in their phenotype, were found in various pathological conditions related to endothelial dysfunction. [11] [12] [13] Interestingly, elevated circulating EMPs were correlated with the degree of impaired artery elasticity in patients with end-stage renal failure.
14 Chronic uremia and hypertension in these patients may affect both MP formation and arterial stiffening, and thus the possibility that elevated EMPs are coproducts along with impaired artery elasticity under adverse stimulation has not been ruled out. Whether EMPs generated under physiological conditions, which are free of apparent risk factors, are correlated with artery properties has not been reported, to our knowledge.
In the present study, we simultaneously measured circulating CD31ϩ/CD42Ϫ MPs and artery elasticity profiles, including brachia-ankle pulse-wave velocity (baPWV), the C1 large-artery elasticity index (C1), and the C2 small-artery elasticity index (C2), using noninvasive devices for pulse-wave analysis in healthy, middleaged subjects living in the same community. We are the first to investigate the relationship between artery elasticity and circulating MPs, mainly of endothelial origin, in healthy, highly functional subjects. This study may provide useful information for further exploration of the crucial role of endothelium involved in artery elasticity alteration.
Methods

Subjects
We recruited 76 healthy volunteers who were eligible for inclusion if (1) they had no clinical cardiovascular disease history such as hypertension, ischemic heart disease, peripheral artery disease, arrhythmia, hyperlipidemia, or diabetes mellitus, and no impaired renal function and other major or acute pathologies; (2) they did not have a heavy smoking habit (Ն10 cigarettes/day) or alcohol abuse (Ն80 g/day); (3) they testified to having normal levels of fasting plasma glucose (2.9 -6 mM), cholesterol (3.1-5.7 mM), triglycerides (0.33-1.7 mM), LDL-c (1.94 -3.61 mM), and highly sensitive C-reactive protein (hsCRP) (0 -3 mg/L) before they were recruited; and (4) they were not on any medications for Ն2 weeks prior to this study. The protocol was approved by the Ethics Committee of Sun Yat-Sen University (Guangzhou, China). All subjects were aware of the investigational nature of the study and gave their written consent. The baseline characteristics of healthy subjects are given in Table 1 .
Procedures
The study was performed in a controlled environment maintained at 23°C, after participants had rested for Ն15 min in supine position. Subjects refrained from consuming alcohol or caffeine and did not smoke for at least 12 h before this study. The measurement of baPWV and C1 and C2 indices was performed. On the same day, a venous blood sample for EMP testing was drawn from the forearm.
Assessment of Hemodynamic Parameters
Hemodynamic parameters were measured in supine individuals after Ն15 min of rest. Blood pressure, baPWV (n ϭ 76), and C1 and C2 indices (n ϭ 56 of 76 volunteers) were measured, using two automatic devices (VP-2000; Colin, Japan) and the CVProfilor DO-2020 CardioVascular System (Hypertension Diagnostics, Eagan, MN) with an Arterial Pulse Wave Sensor (Perimed, Järffala, Sweden), as described previously. 5, 15 The intraobserver repeatability coefficients of baPWV and the C1 and C2 indices were 0.90 and 0.91, respectively. The interobserver repeatability coefficients of baPWV and the C1 and C2 indices were 0.95 and 0.94, respectively. The baPWV was expressed as centimeters per second (cm/sec). The C1 and C2 indices were expressed as mL/mm Hg ϫ 10 and mL/mm Hg ϫ 100, respectively.
CD31؉/CD42؊ MP Isolation and Immunolabeling
Circulating CD31ϩ/CD42Ϫ MPs were isolated from 4 mL of venous citrated blood drawn from the forearm, as described previously. 12, 16 Briefly, platelet-free plasma was separated from the 4-mL blood sample by centrifugation at 160 g (10 min) and then 1000 g (6 min). Fifty microliters of the plasma were incubated with anti-CD31-PE (5 L/ test) and anti-CD42b-FITC (5 L/test) antibodies, or their respective isotypic immunoglobulins (all from Beckman Coulter, France), at room temperature for 30 min in the dark with regular shaking. 
BMI ϭ body mass index; DBP ϭ diastolic blood pressure; FPG ϭ fasting plasma glucose; HDL-c ϭ high-density lipoprotein cholesterol; hsCRP ϭ highly sensitive C-reactive protein; LDL-c ϭ lowdensity lipoprotein cholesterol; PP ϭ pulse pressure; SBP ϭ systolic blood pressure; TC ϭ total cholesterol; TG ϭ triglycerides.
Values are expressed as mean Ϯ SD.
Flow Cytometric Analysis
Samples were analyzed on an EPICS Altra (Beckman Coulter), as previously described, 12, 16 by an independent examiner who was unaware of the subjects' status. After using an isotypic control to exclude nonspecific fluorescence, events with a 0.1 to 1-m diameter, calibrated by 1-m calibrator beads (Beckman Coulter), were identified in forward-scatter and side-scatter intensity dot representation, gated as MPs, and plotted on one-or two-color fluorescence histograms. The CD31ϩ/CD42Ϫ MPs were defined as elements that had a size Ͻ1 m and Ͼ0.1 m, positively labeled by anti-CD31-PE and negatively labeled by anti-CD42b-FITC (CD31ϩ/CD42bϪ MPs), ie, the B1 section in histograms (Fig. 1B) . The absolute concentration of circulating CD31ϩ/CD42Ϫ MPs was calculated using Flowcount Calibrator Beads (Beckman Coulter) with known concentrations provided by manufacturer, which were added (50 L/test) into the sample right before flow cytoanalysis. The final numbers of CD31ϩ/ CD42Ϫ MPs were expressed as microparticles per microliter.
Statistical Analysis
Data are expressed as mean Ϯ SEM. Quantitative variables of CD31ϩ/CD42Ϫ MPs with non-normal distribution were log-transformed to achieve normal distribution before correlation analysis. Statistical analysis was performed with SPSS 10.0 software for Windows (SPSS, Inc., Chicago, IL). Multivariate linear correlation analysis was performed using the Pearson coefficient of correlation.
Stepwise regression was used to analyze associations between artery elasticity parameters as dependent variables and levels of circulating CD31ϩ/CD42Ϫ MPs, as well as other variables, identified as significantly correlated with artery elasticity parameters as independent variables. The levels of circulating CD31ϩ/CD42Ϫ MPs were subsequently tested in a partial correlation analysis with artery elasticity parameters. Values of P Ͻ .05 were considered statistically significant.
Results
Mean values of baPWV and of C1 large-and C2 smallartery elasticity indices, recorded in healthy subjects, were 1379 Ϯ 194 (cm/sec), 11.7 Ϯ 4.0 (mL/mm Hg ϫ 10), and 4.8 Ϯ 2.6 (mL/mm Hg ϫ 100), respectively. The BaPWV was robustly related to age (r ϭ 0.490, P Ͻ . 001), systolic blood pressure (BP) (r ϭ 0.577, P Ͻ . 001), diastolic BP (r ϭ 0.409, P ϭ .001), mean BP (r ϭ 0.583, P Ͻ . 001), and pulse pressure (r ϭ 0.327, P ϭ .004) ( Fig. 2 and Table  2 ). The C1 and C2 indices were significantly correlated with age (C1, r ϭ Ϫ0.360, P ϭ .007; C2, r ϭ Ϫ0.321, P ϭ .018), systolic BP (C1, r ϭ Ϫ0.364, P Ͻ . 001; C2, r ϭ Ϫ0.293, P ϭ .031), mean BP (C1, r ϭ Ϫ0.368, P ϭ .006; C2, r ϭ Ϫ0.313, P ϭ .021), and pulse pressure (C1, r ϭ Ϫ0.327, P ϭ .004; C2, r ϭ Ϫ0.266, P ϭ .05) (Fig. 2 and Table 2 and fasting plasma glucose, lipid profiles, and serum hsCRP levels.
The number of circulating CD31ϩ/CD42Ϫ MPs was 1111 Ϯ 661/7L. Significant relationships were found between circulating CD31ϩ/CD42Ϫ MPs (log-transformed) and systolic BP (r ϭ 0.305, P ϭ .009), mean BP (r ϭ 0.302, P ϭ .009), baPWV (r ϭ 0.371, P ϭ .008), C1 (r ϭ Ϫ0.294,P ϭ .037), and C2 (r ϭ Ϫ0.310, P ϭ .027) (Fig. 3 and Table 2 ). Controlling for age and mean BP, ie, the two major determinants of artery elasticity, the number of circulating CD31ϩ/CD42Ϫ MPs was still significantly related to baPWV (r ϭ 0.276, P ϭ .02), C1 (r ϭ Ϫ0.321, P ϭ .025), and C2 (r ϭ Ϫ0.340, P ϭ .017). Multiple regression analysis demonstrated a persistent relationship between circulating CD31ϩ/CD42Ϫ MPs and baPWV, C1, and C2 (Table 3) . However, we failed to find a significant relationship between fasting plasma glucose, lipid profiles, hsCRP, and circulating CD31ϩ/CD42Ϫ MPs.
Discussion
The present study is the first to investigate the relationship between systemic artery elasticity and the CD31ϩ/ CD42Ϫ MPs that represent the degree of endothelial dys- 
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function in a group of healthy individuals. The major findings are that the numbers of circulating CD31ϩ/ CD42Ϫ MPs are positively correlated with the deterioration of artery elasticity profiles measured by baPWV and C1 large-artery and C2 small-artery elasticity indices. A multivariate analysis, correcting for age and baseline BP, identified circulating CD31ϩ/CD42Ϫ MPs as potent indicators of impaired artery elasticity. Our data demonstrated that endothelial function is an important determinant in regulating artery elasticity in vivo in healthy subjects.
The measurement of artery elasticity may provide clinical relevance for the evaluation of vascular homeostasis. Several methods were developed to assess artery elasticity, including pulse-wave analysis. The measurement of baPWV was developed recently and is closely correlated with carotid-femoral pulse-wave velocity, a noninvasive standard measure of large-artery elasticity. 17 Our study showed that in healthy persons, baPWV is related to both aging and baseline BP. We also found that a systemic decline in artery-elasticity indices (C1 and C2) happens coincidently with age and baseline BP elevation. Our present findings, together with previous studies, 18 demonstrate that both baPWV and C1 and C2 are similarly valuable methods for the detection of in vivo systemic artery elasticity alterations.
Chronic resting artery elasticity is usually considered to be related to both structural changes in the arterial wall and endothelial dysfunction. 4, 7 Evaluation of endothelial function in vivo, such as evaluation of endothelial function such as flow-mediated vasodilation, serum nitric oxide (NO) productions was reported closely related to artery elasticity in selected patients. 19 But because the existing risk factors may affect both endothelial function and artery elasticity properties simultaneously, the relationship between endothelial dysfunction and artery elasticity has not been well described in healthy individuals who are free of the potentially confounding influences of cardiovascular disease.
Increased circulating EMPs were found to be closely related to diminished endothelial structural and functional integrity. 10 Our data showed that the number of circulating CD31ϩ/CD42Ϫ MPs was positively correlated with baseline BP levels. Along with the evidence that reduced NO bioactivity in endothelium was also found in the hypertensive condition, 8 our data indicate that endothelial dysfunction may be one key event in the onset of hypertension and hypertensive deterioration. The most important findings of this study are that even under physiologic conditions, the circulating CD31ϩ/CD42Ϫ MPs are strongly correlated with deterioration of elasticity, both in large (baPWV and C1) and small (C2) arteries. Correcting for age and BP, the two determinants of artery elasticity, the circulating CD31ϩ/CD42Ϫ MPs stay positive involved. This finding suggests that increased circulating CD31ϩ/ CD42Ϫ MPs may serve not only as a surrogate parameter of systemic endothelial dysfunction but also as a linkage in Table 2 . Correlation analysis of brachia-ankle pulse-wave velocity, C1 and C2 artery elasticity indices, age, blood-pressure profiles, lipid, glucose, highly sensitive C-reactive protein, and log-transformed values of CD31ϩ/CD42Ϫ microparticles Brachia-ankle pulse-wave velocity (cm/sec) C1 (mL/mm Hg the interaction between the endothelium monolayer and alterations in whole-artery elasticity.
In this study, we found that circulating CD31ϩ/ CD42Ϫ MPs are positively related to BP levels. However, we failed to find a relationship between CD31ϩ/CD42Ϫ MPs and age, though aging was proved to be an adverse factor that impairs endothelium. 20 There were reports that elevated circulating EMPs were found in patients with type 2 diabetes mellitus and in healthy persons with postprandial hypertriglyceridemia, 21, 22 but our data failed to demonstrate relationships between fasting plasma glucose, lipid profiles, and circulating CD31ϩ/CD42Ϫ MPs. The subjects we studied were in good health, with fasting plasma glucose and lipid profiles in a narrow range. The discrepancy between our study and previous observations may be due to differing sets of subjects and protocols.
Endothelial MPs per se were demonstrated to have multiple potentials in modulating leukocyte function and procoagulant activities in vitro. 10 Recent studies showed that EMPs impair acetylcholine-induced vasorelaxation and nitric oxide production of rat aortic rings in a dosedependent manner, 23 and affect angiogenesis by inducing oxidative stress in cultured endothelial cells. 24 In healthy subjects who were free of major cardiovascular risk factors, circulating CD31ϩ/CD42Ϫ MPs, representing endothelial perturbation, were closely related to systemic artery stiffness. Our cross-sectional study further supported that EMPs may independently facilitate the alteration of endothelium to a proarteriosclerosis phenotype, thus contributing to the development of vascular diseases.
It should be pointed out that there are some limitations in our study. First, its small sample size and lack of prospective data limit our ability to infer causal relationships among variables. Large, prospective investigations and in vitro experiments would be required to confirm whether CD31ϩ/CD42Ϫ MPs affect endothelial function, and their underlying mechanisms need to be further elucidated. Second, although CD31ϩ/CD42Ϫ MPs, it has ruled out the platelet MPs which take large part of circulating MPs, may also include CD31ϩ MPs of leukocyte origin. However, according to Pirro et al, 25 a negligible number of leukocyte (CD31ϩ/CD45ϩ) MPs contaminating the whole CD31ϩ MP population (Ͻ5%). Third, we used baPWV, the surrogate marker of aortic pulse-wave velocity, to evaluate large-artery elasticity, because baPWV proved to be closely related to aortic pulse-wave velocity and had been used in previous studies. 17, 26 In conclusion, the level of circulating CD31ϩ/ CD42Ϫ MPs is an important biomarker of dysfunctional endothelium and vascular injury. Circulating CD31ϩ/CD42Ϫ MPs are closely associated with functional alterations of systemic artery elasticity in healthy persons who are free of major cardiovascular risk factors. These combined measurements of both endothelium and vascular status should be a far more sensitive and specific marker for the early evaluation of vascular homeostasis than the traditional application of associated risk factors. 
